Skip to content

Multi-center practical randomized controlled study on acupoint application of traditional Chinese medicine in the treatment of children's acute sore throa

Multi-center practical randomized controlled study on acupoint application of traditional Chinese medicine in the treatment of children's acute sore throa

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006384
Enrollment
Unknown
Registered
2022-07-28
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute upper respiratory infections

Interventions

Test group:Traditional Chinese medicine acupressure combined with western medicine conventional treatment

Sponsors

XiYuan Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for acute upper respiratory tract infection with a painful swallowing Wong-Baker Facial Expression Pain Scale (WBS) pain score = 4. (2) Age = 3 years and = 14 years. (3) No restriction on gender. (4) No more than 48 hours between onset and consultation. (5) All children and their guardians voluntarily participated in this trial and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with combined acute laryngitis, otitis media, pneumonia, bronchitis (2) Those suffering from infectious diseases (measles, scarlet fever, etc.) (3) heart, liver, kidney and other organ failure or serious metabolic, hematological or neurological diseases (4) Those who are malnourished or immunodeficient (5) Drugs or non-drug treatments used within 24 hours prior to registration (6) Those with skin lesions on the patching site, such as scarring and ulcers. (7) Those with abnormal sweat secretion with phytonadic dysfunction (8) Those who are allergic to known test drugs. (9) Those who are participating in other studies, or receiving similar topical interventions.

Design outcomes

Primary

MeasureTime frame
Clinical efficiency of sore throat at 3 and 5 days of treatment;

Secondary

MeasureTime frame
Evaluation of other symptoms (systemic symptoms, upper respiratory tract symptoms, other symptoms of the pharynx);Antibiotic use;Time for sore throat to disappear;

Countries

China

Contacts

Public ContactGaoRui

XiYuan Hospital of CACMS

ruigao@126.com13911097756

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026